It is known that 5-HT2a receptor blockade by clozapine favors a selective stimulation of 5-HT1a receptors.[12] Our patient had been taking chlorpromazine for 10 years and NMS is known to occur during the first month of treatment with conventional anti-psychotics. The gene discussed is HTR1A; the disease is neuroleptic malignant syndrome.